Our experienced analysts and consultants undertake a systematic collection and evaluation of past/present disease epidemiology, pipeline assets, clinical development programs and regulatory/patent strategies. This can help to identify internal and external forces that may influence organisational performance, as well as yielding an assessment of current and future strengths, weaknesses, opportunities, and potential strategies.